Circulating tumour DNA analysis to direct therapy in advanced breast cancer (plasmaMATCH): a multicentre, multicohort, phase 2a, platform trialNicholas C. Turner, Alistair Ring, Jeremy Braybrooke et al.|The Lancet Oncology|2020Cited by 351
Tracking evolution of aromatase inhibitor resistance with circulating tumour DNA analysis in metastatic breast cancerCharlotte Fribbens, Nicholas C. Turner, Isaac García-Murillas et al.|Annals of Oncology|2017Cited by 158
Genomic profile of advanced breast cancer in circulating tumour DNABelinda Kingston, Nicholas C. Turner, Rosalind Cutts et al.|Nature Communications|2021Cited by 95
First mature analysis of the Intergroup Exemestane StudyR. Charles Coombes, Judith M. Bliss, Robert Paridaens et al.|Journal of Clinical Oncology|2006Cited by 65
Adjuvant chemotherapy in older women (ACTION) study – what did we learn from the pilot phase?Robert Leonard, Judith M. Bliss, Rachel Ballinger et al.|British Journal of Cancer|2011Cited by 50